At Ketavita Wellness Clinic, we offer specialized ketamine therapy for sleep disturbances that occur as part of treatment-resistant depression. When insomnia, nighttime restlessness, early morning awakening, or other sleep problems persist despite treatment for depression, our IV and IM ketamine infusions provide an approach that targets both mood and sleep through rapid-acting glutamatergic mechanisms.
Located in Wyckoff, New Jersey, our clinic provides evidence-based care from experienced medical professionals who understand the complex relationship between depression and sleep. We create personalized treatment protocols designed to help you achieve meaningful improvements in both depressive symptoms and sleep quality.
It’s important to understand that our ketamine therapy specifically treats sleep disturbances related to major depressive disorder or bipolar disorder. We do not treat primary sleep disorders like sleep apnea, narcolepsy, or restless legs syndrome. Every treatment journey begins with a comprehensive evaluation where we review your depression history and treatment response, sleep disturbance patterns including difficulty falling asleep, staying asleep, or early morning awakening, whether sleep problems preceded or followed your mood symptoms, previous treatments tried for both depression and sleep, current medications including sleep aids, and how sleep disturbances affect your functioning and quality of life. This assessment helps determine whether ketamine therapy is appropriate for your depression-related sleep problems.
Sleep disturbances affect up to 90% of people with depressive disorders, making them one of the most common and persistent symptoms of depression. These disturbances manifest in various patterns including insomnia with difficulty falling asleep or staying asleep, early morning awakening where you wake hours before intended and cannot return to sleep, nighttime restlessness with frequent awakenings throughout the night, non-restorative sleep where you sleep adequate hours but wake feeling unrefreshed, and in some cases hypersomnia or excessive sleep.
The relationship between depression and sleep is bidirectional and complex. Depression alters sleep architecture—the natural progression through sleep stages—disrupting the normal cycling between non-REM and REM sleep. Depressed individuals often show reduced slow wave sleep (the deepest, most restorative stage), altered REM sleep patterns including earlier onset and increased density, and overall sleep fragmentation with frequent awakenings.
Poor sleep, in turn, worsens depression. Sleep disturbances exacerbate depressive symptoms including fatigue, concentration problems, and emotional dysregulation. They increase risk of treatment resistance, making standard antidepressants less effective. Sleep problems predict higher rates of relapse and recurrence of depressive episodes. Perhaps most concerningly, severe insomnia significantly increases suicide risk in depressed individuals.
This vicious cycle creates a clinical challenge: which should be treated first, depression or sleep? Traditional approaches often involve adding sedating medications to antidepressants or prescribing separate sleep aids. However, many patients continue experiencing both mood and sleep problems despite these interventions, meeting criteria for treatment-resistant depression with residual sleep disturbances.
Sleep disturbances also affect circadian rhythms—the internal biological clock regulating sleep-wake cycles. Depression is associated with circadian rhythm disruptions including phase delays where individuals feel alert late at night but struggle to wake in the morning, reduced amplitude of circadian rhythms making sleep-wake patterns less distinct, and desynchronization between internal biological time and environmental time. These rhythm disturbances further perpetuate both mood and sleep problems.
The persistence of sleep problems matters clinically. Residual insomnia—sleep disturbances that persist despite mood improvement—is common even among patients whose depression responds to treatment. Studies show that 30-50% of patients achieving depression remission continue experiencing significant sleep problems. These residual symptoms predict higher relapse rates and reduced quality of life.
Ketamine functions as a noncompetitive antagonist of NMDA receptors, blocking excessive glutamatergic signaling implicated in both depression and sleep regulation. Through NMDA receptor antagonism, ketamine initiates a molecular cascade increasing synaptic strength, neuroplasticity, and brain-derived neurotrophic factor (BDNF) levels. These neuroplastic changes drive ketamine’s rapid antidepressant effects—improvements occurring within hours to days rather than the weeks required for conventional antidepressants.
Research increasingly suggests that ketamine’s effects on sleep may partially mediate its antidepressant action. Studies using electroencephalography (EEG) to measure brain wave activity during sleep show that ketamine increases total sleep time in depressed individuals who respond to treatment. Rapid antidepressant responders show increased slow wave sleep, the deepest and most restorative stage of non-REM sleep that is typically deficient in depression. Ketamine increases slow wave activity—the power of delta frequency brain waves characteristic of deep sleep. Some studies show increased REM sleep, though findings vary.
Importantly, baseline sleep architecture predicts ketamine response. Research shows that individuals with low delta sleep ratio—a measure indicating deficient early-night slow wave sleep production—are more likely to respond rapidly to ketamine treatment. This suggests ketamine may work partly by correcting sleep homeostatic deficits that contribute to depression maintenance.
Ketamine also affects circadian rhythm regulation. Studies show that ketamine alters circadian gene expression in brain regions involved in mood regulation. In rapid responders versus non-responders, ketamine differentially affects the timing and amplitude of circadian activity patterns. These findings suggest ketamine may resynchronize disrupted biological clocks contributing to both depression and sleep disturbances.
The glutamate system plays critical roles in both mood regulation and sleep-wake control. By modulating glutamatergic transmission through NMDA receptor antagonism, ketamine may simultaneously address the neural mechanisms underlying depression and its associated sleep disturbances. This dual action distinguishes ketamine from conventional antidepressants that primarily target monoamine systems.
Clinical studies examining sleep outcomes during ketamine treatment show improvements across multiple sleep parameters. Patient-reported measures demonstrate reductions in insomnia severity, decreased nighttime restlessness, less frequent early morning awakening, and improved overall sleep quality. These improvements occur alongside antidepressant effects, often within the same rapid timeframe.
Your treatment journey at Ketavita begins with a thorough evaluation to determine whether ketamine therapy is appropriate for your depression-related sleep disturbances. We’ll discuss your depression history in detail including diagnosis (major depressive disorder or bipolar disorder), duration of current episode, previous depressive episodes and treatment response, whether you meet criteria for treatment-resistant depression, and current depressive symptoms beyond sleep problems.
Understanding your sleep disturbance pattern is essential: when sleep problems began relative to depression onset, specific patterns including difficulty falling asleep, staying asleep, early awakening, or hypersomnia, how sleep problems vary across depressive episodes, typical sleep schedule and duration, impact of sleep disturbances on daytime functioning, and whether you have other sleep disorders like sleep apnea that require separate evaluation.
We’ll review your complete treatment history including all antidepressants tried with doses, durations, and outcomes, current psychiatric medications, medications tried specifically for sleep including hypnotics and sedating antidepressants, behavioral interventions like cognitive behavioral therapy for insomnia (CBT-I), and response to each treatment. This comprehensive assessment determines whether your sleep disturbances are secondary to treatment-resistant depression and whether ketamine therapy might help.
For ketamine therapy targeting depression and associated sleep disturbances, we offer both IV and IM ketamine administration. Treatment typically involves a series of infusions over several weeks, with the initial series establishing response. During each session, you’ll receive your ketamine infusion while resting in a private, comfortable treatment room. We monitor your vital signs continuously throughout treatment.
You may experience dissociative effects during the infusion—feelings of detachment, altered perception, or mild changes in how you experience your surroundings. These effects are temporary and typically resolve within 1-2 hours after the infusion ends. Common side effects are generally mild and short-lasting including temporary dissociative sensations during and shortly after infusion, dizziness or lightheadedness, mild nausea, brief changes in perception, drowsiness, and temporary blood pressure elevation.
After each treatment session, you’ll spend additional time in our office for recovery and monitoring before leaving. You cannot drive for 24 hours after ketamine treatment and must bring someone to drive you home.
Response to ketamine therapy varies among individuals. Research shows that approximately 50-70% of patients with treatment-resistant depression experience significant mood improvement with ketamine treatment. Among responders, many also report improvements in sleep quality, with reductions in insomnia severity, nighttime restlessness, and early morning awakening often occurring alongside mood improvements.
The timeline of improvement can vary. Some patients notice better sleep within days of their first infusion, coinciding with rapid antidepressant effects. Others experience more gradual improvements across multiple treatments. We track your response using standardized measures of both depression severity and sleep quality to assess treatment effectiveness and guide protocol adjustments.
Ketamine therapy for depression-related sleep disturbances may be appropriate if you have treatment-resistant depression with persistent sleep problems. You may be a candidate if you have major depressive disorder or bipolar disorder with significant sleep disturbances, have tried and failed adequate trials of at least two different antidepressant medications, continue experiencing both depressive symptoms and sleep problems despite treatment, have sleep disturbances that are clearly related to your mood disorder rather than a primary sleep disorder, and remain significantly impaired by the combination of mood and sleep symptoms.
Good candidates are adults with treatment-resistant depression whose sleep disturbances are secondary to their mood disorder. The evidence for ketamine improving sleep comes specifically from studies of depressed patients, showing that sleep improvements occur as part of the antidepressant response. Ketamine is not indicated for and has not been shown effective for primary sleep disorders unrelated to depression.
Certain factors may affect treatment suitability. During evaluation, we review cardiovascular health since ketamine temporarily raises blood pressure, history of psychotic symptoms, substance use history, current medications including sleep aids and their effectiveness, and whether you have primary sleep disorders like sleep apnea requiring separate evaluation and treatment. Your comprehensive evaluation ensures safe, appropriate treatment.
Important limitations to understand: ketamine treats depression-related sleep disturbances, not primary sleep disorders. If you have sleep apnea, narcolepsy, or other primary sleep conditions, those require evaluation and treatment by sleep medicine specialists. Ketamine therapy for sleep problems represents off-label use, with evidence coming from studies examining sleep as a secondary outcome in depression trials rather than studies specifically targeting sleep disorders. We discuss these considerations during consultation.
Our ketamine protocols for treatment-resistant depression with sleep disturbances are informed by systematic reviews and clinical trials examining sleep outcomes during ketamine treatment. A 2023 systematic review examining ketamine’s effects on sleep in treatment-resistant depression found that five studies reported improvements in sleep quality measures including reductions in insomnia, nighttime restlessness, and early morning awakening. These improvements occurred alongside antidepressant effects.
A 2024 patient-reported outcomes study examined 323 patients with treatment-resistant depression receiving IV ketamine treatment. Results showed significant improvements in sleep disturbances measured by sleep-related items on depression rating scales, with benefits in falling asleep, staying asleep, and early morning awakening. These improvements occurred within the treatment series and were maintained through follow-up.
Objective EEG studies demonstrate that ketamine alters sleep architecture in ways that may contribute to antidepressant effects. Research shows increases in total sleep time, slow wave sleep, and slow wave activity—all of which are typically deficient in depression. These changes in sleep quality may partially mediate ketamine’s rapid antidepressant action.
Safety is paramount in all our treatments. Ketamine has been used safely in medical settings for decades, and we follow established safety protocols for subanesthetic dosing. All treatments are administered by licensed medical professionals with appropriate training, monitoring equipment, and emergency protocols.
We recognize that optimal outcomes for depression-related sleep disturbances require comprehensive treatment. While ketamine may provide rapid improvements in both mood and sleep, we strongly encourage continued engagement with comprehensive care including appropriate maintenance antidepressant treatment if beneficial, behavioral interventions for sleep including sleep hygiene education and CBT-I when appropriate, treatment of any co-occurring conditions, management of medications that may affect sleep, and regular follow-up with mental health providers.
Good sleep hygiene remains essential regardless of treatment approach. We educate patients about maintaining consistent sleep-wake schedules even on weekends, creating a sleep-conducive bedroom environment that’s dark, quiet, and cool, limiting screen time before bed, avoiding caffeine late in the day and alcohol before sleep, and engaging in regular physical activity but not too close to bedtime. These behavioral interventions complement ketamine therapy.
Patient education is central to our approach. We ensure you understand how ketamine works differently from conventional antidepressants, what current research shows about effects on sleep in depressed patients, realistic expectations given individual variability in response, the distinction between treating depression-related sleep problems versus primary sleep disorders, potential side effects or risks, and how ketamine fits into comprehensive depression and sleep management.
Ketamine therapy for treatment-resistant depression is typically not covered by insurance as it represents off-label use. We provide transparent pricing information during your consultation so you can make informed decisions about treatment.
IV ketamine therapy for mental health conditions is $395 per session. IM ketamine therapy is also $395 per session. Treatment protocols typically involve a series of 6-8 infusions over 2-4 weeks for the initial treatment phase, with the specific number based on individual response. Some patients require maintenance infusions to sustain benefits.
The total investment depends on your treatment protocol, response to therapy, and whether maintenance sessions are needed. We discuss expected treatment courses during your consultation based on current evidence and clinical experience.
While insurance typically doesn’t cover ketamine therapy, we can provide receipts and clinical documentation that you may submit to your insurance company for possible out-of-network reimbursement. For an additional $50 fee, we can prepare detailed documentation for insurance submission. Coverage decisions are made by individual insurance companies based on their policies, and approval is not guaranteed.
If you’ve been struggling with treatment-resistant depression and persistent sleep problems despite trying multiple treatments, ketamine therapy at Ketavita Wellness Clinic may offer hope. Our approach provides rapid-acting treatment that addresses both mood and sleep through mechanisms distinct from conventional antidepressants.
Schedule a consultation to discuss your depression and sleep history, review treatment trials you’ve completed, explore whether ketamine therapy is appropriate for your situation, and develop a personalized treatment plan if you proceed with treatment.
Living with both depression and chronic sleep disturbances creates profound disability, but emerging treatments offer new possibilities. Contact us today to learn whether ketamine therapy might help you achieve improvements in both mood and sleep quality.
No. Our ketamine therapy specifically treats sleep disturbances that occur as part of treatment-resistant depression. Ketamine is not indicated for and has not been shown effective for primary sleep disorders like sleep apnea, narcolepsy, restless legs syndrome, or insomnia unrelated to mood disorders. These conditions require evaluation and treatment by sleep medicine specialists.
Research shows ketamine improves sleep through multiple mechanisms. It increases total sleep time, slow wave sleep (deep sleep), and slow wave activity that are typically deficient in depression. It may help resynchronize disrupted circadian rhythms. These changes in sleep architecture occur alongside antidepressant effects and may partially mediate ketamine’s rapid mood improvements.
Ketamine therapy at our clinic is specifically for depression-related sleep disturbances. The evidence supporting ketamine for sleep problems comes exclusively from studies of depressed patients, where sleep improvements occur as part of the antidepressant response. We do not treat primary insomnia unrelated to mood disorders.
Timeline varies among individuals. Some patients notice improved sleep within days of their first infusion, coinciding with rapid antidepressant effects. Others experience more gradual improvements across multiple treatments. Research shows that sleep improvements typically parallel mood improvements during ketamine treatment.
Never discontinue medications without consulting your prescribing physician. Most patients continue their current medications during ketamine treatment. We review all your medications during consultation to ensure there are no contraindications. If ketamine therapy proves effective, your prescribing physician can determine whether medication adjustments are appropriate.
Duration varies among individuals who respond to ketamine treatment. Some patients experience sustained improvements in both mood and sleep lasting weeks to months after an initial treatment series. Others require periodic maintenance treatments. Individual response patterns help guide maintenance scheduling.
Ketamine targets the underlying depression contributing to sleep disturbances through rapid neuroplastic mechanisms, potentially improving both mood and sleep simultaneously. Traditional sleep medications treat sleep symptoms directly but don’t address underlying mood pathology. For depression-related sleep problems, treating the depression itself often provides more durable sleep improvements.
The dissociative effects of ketamine occur during and shortly after infusion and resolve within 1-2 hours. Research shows that depressed patients responding to ketamine often report increased energy and improved daytime functioning along with better nighttime sleep. However, you cannot drive for 24 hours after treatment.
Sleep apnea requires evaluation and treatment by sleep medicine specialists, typically with CPAP or other interventions. If you also have treatment-resistant depression with sleep disturbances beyond sleep apnea, ketamine therapy might help the depression-related components of your sleep problems. Comprehensive evaluation determines the appropriate treatment approach.
Neurological & Sleep Disorders
Conditions Treated
365 Franklin Avenue, Wyckoff, NJ 07481